Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6288]

Combining three treatment strategies may significantly improve melanoma treatment

Combining three treatment strategies may significantly improve melanoma treatment

Researchers develop personalised medicine tool for inherited colorectal cancer syndrome

Researchers develop personalised medicine tool for inherited colorectal cancer syndrome

Sprayable gel could help the body fight off cancer after surgery

Sprayable gel could help the body fight off cancer after surgery

SABCS 2018: Black women have worse breast cancer outcomes despite receiving similar treatment as white women

SABCS 2018: Black women have worse breast cancer outcomes despite receiving similar treatment as white women

SABCS 2018: Phase III KATHERINE clinical trial crossed early reporting boundary and met its primary endpoint

SABCS 2018: Phase III KATHERINE clinical trial crossed early reporting boundary and met its primary endpoint

SABCS 2018: Adjuvant capecitabine did not significantly improve outcomes for patients with early-stage triple-negative breast cancer

SABCS 2018: Adjuvant capecitabine did not significantly improve outcomes for patients with early-stage triple...

ASH 2018: Machine learning-based model improves prognosis accuracy for myelodysplastic syndromes

ASH 2018: Machine learning-based model improves prognosis accuracy for myelodysplastic syndromes

ASH 2018: Rapid genetic screening shows feasibility of precision medicine for acute myeloid leukaemia

ASH 2018: Rapid genetic screening shows feasibility of precision medicine for acute myeloid leukaemia

ASH 2018: Inhibiting the immune system’s natural response may boost benefits and sustainability of CAR T therapy

ASH 2018: Inhibiting the immune system’s natural response may boost benefits and sustainability of CAR T therapy

ASH 2018: Concurrent ibrutinib may improve outcomes, reduce toxicity of CAR T-Cell Therapy with JCAR014 for CLL

ASH 2018: Concurrent ibrutinib may improve outcomes, reduce toxicity of CAR T-Cell Therapy with JCAR014 for CLL

More from ecancer